Independent global mid-market investment banking firm Alantra has appointed Nick Johnston as a senior advisor in its healthcare sector team, which comprises more than 30 professionals across Europe, the US and Asia who have completed more than 20 deals over the past year. will be based in London.

Johnston’s 25-year career spans both investment banking advisory and industry positions in the UK and US. He has held senior positions in the healthcare investment banking teams at Perella Weinberg and J.P. Morgan advising companies across multiple subsectors with a particular focus in biotechnology, medical technology, diagnostics and digital health. He was also chief operating officer of a specialist medical device developer and co-founded a development-stage drug discovery company in respiratory health and other indications. He also sits on the board of a medical device company. 

Justin Crowther, Alantra partner and UK head of healthcare, said: “Nick is a highly respected advisor across the biotechnology, medical technology, diagnostics and digital health sectors and his appointment strengthens our healthcare team in the UK and globally. He reinforces our commitment to ensuring our clients are working with world-class advisors who have in-depth sector expertise and relationships, an excellent transaction track record and industry experience.”

Johnston added: “Healthcare is one of the most active sectors for M&A and there are often numerous options available to business owners and management teams seeking investment or other strategic solutions. Navigating these options requires a combination of deep sector expertise – especially in a sector as complex and dynamic as healthcare – and broad experience in the many facets of corporate finance. Alantra’s engaged global team of senior healthcare advisors is well positioned to meet these needs as companies research, develop and, if necessary, start commercialising their technology.”